The Texas Drug Utilization Review Board meets quarterly to develop criteria and standards impacting Texas Medicaid, including:
- Developing and submitting recommendations for the Texas Medicaid preferred drug list
- Suggesting clinical prior authorizations on outpatient prescription drugs.
- Recommending educational interventions for Medicaid providers.
- Reviewing drug utilization across the Medicaid program.
February 26, 2020
Revised Growth Hormone Clinical Prior Authorization Begins May 28
February 7, 2020
January 2020 Drug Utilization Review Board Meeting Summary